Drugmaker Eli Lilly plans to invest $3 billion to expand a manufacturing facility in the Kenosha County, Wis., to meet growing demand for its diabetes and weight-loss medicines.
Mounjaro will be made available on the NHS but the rollout will be phased - only those with the highest need will get the jabs first meaning millions face a long wait ...